Yamashita YT - Search Results

1

Elevated serum sialyl Lewis X-i antigen levels in non-small cell lung cancer with lung metastasis.

Satoh H, Ishikawa H, Kamma H, Yamashita YT, Takahashi H, Ohtsuka M, Hasegawa S. Satoh H, et al. Among authors: yamashita yt. Respiration. 1998;65(4):295-8. doi: 10.1159/000029279. Respiration. 1998. PMID: 9730796 Clinical Trial.

2

Cut-off levels of NSE to differentiate SCLC from NSCLC.

Satoh H, Ishikawa H, Kurishima K, Yamashita YT, Ohtsuka M, Sekizawa K. Satoh H, et al. Among authors: yamashita yt. Oncol Rep. 2002 May-Jun;9(3):581-3. Oncol Rep. 2002. PMID: 11956631

3

Time from finding abnormality on mass-screening to final diagnosis of lung cancer.

Kanashiki M, Satoh H, Ishikawa H, Yamashita YT, Ohtsuka M, Sekizawa K. Kanashiki M, et al. Among authors: yamashita yt. Oncol Rep. 2003 May-Jun;10(3):649-52. Oncol Rep. 2003. PMID: 12684638

4

Production of cytokeratin 19 fragment by human squamous lung cancer cell lines.

Satoh H, Ishikawa H, Fujiwara M, Yamashita YT, Ohtsuka M, Ogata T, Hasegawa S, Kamma H. Satoh H, et al. Among authors: yamashita yt. Am J Respir Cell Mol Biol. 1997 May;16(5):597-604. doi: 10.1165/ajrcmb.16.5.9160842. Am J Respir Cell Mol Biol. 1997. PMID: 9160842

5

Oculomotor nerve palsy caused by lung cancer metastasis.

Ishikawa H, Satoh H, Fujiwara M, Kamma H, Yamashita YT, Naito T, Ohtsuka M, Hasegawa S. Ishikawa H, et al. Among authors: yamashita yt. Intern Med. 1997 Apr;36(4):301-3. doi: 10.2169/internalmedicine.36.301. Intern Med. 1997. PMID: 9187571 Free article.

6

Outcome of patients with lung cancer detected by mass screening versus presentation with symptoms.

Satoh H, Ishikawa H, Yamashita YT, Naito T, Takahashi H, Kamma H, Saito Y, Ohtsuka M, Hasegawa S. Satoh H, et al. Among authors: yamashita yt. Anticancer Res. 1997 May-Jun;17(3C):2293-6. Anticancer Res. 1997. PMID: 9216704

7

Elevated sialyl Lewis X-i antigen levels in pleural effusions in patients with carcinomatous pleuritis.

Ishikawa H, Satoh H, Kamma H, Naito T, Yamashita YT, Ohtsuka M, Hasegawa S. Ishikawa H, et al. Among authors: yamashita yt. Intern Med. 1997 Oct;36(10):685-9. doi: 10.2169/internalmedicine.36.685. Intern Med. 1997. PMID: 9372327 Free article.

8

Pleural effusion as a significant prognostic factor in non-small cell lung cancer.

Naito T, Satoh H, Ishikawa H, Yamashita YT, Kamma H, Takahashi H, Ohtsuka M, Hasegawa S. Naito T, et al. Among authors: yamashita yt. Anticancer Res. 1997 Nov-Dec;17(6D):4743-6. Anticancer Res. 1997. PMID: 9494600

9

Angiocytotoxic therapy in human non-small cell lung cancer cell lines--advantage of combined effects of TNP-470 and SN-38.

Satoh H, Ishikawa H, Fujimoto M, Fujiwara M, Yamashita YT, Yazawa T, Ohtsuka M, Hasegawa S, Kamma H. Satoh H, et al. Among authors: yamashita yt. Acta Oncol. 1998;37(1):85-90. doi: 10.1080/028418698423221. Acta Oncol. 1998. PMID: 9572659

10

Combined effects of TNP-470 and taxol in human non-small cell lung cancer cell lines.

Satoh H, Ishikawa H, Fujimoto M, Fujiwara M, Yamashita YT, Yazawa T, Ohtsuka M, Hasegawa S, Kamma H. Satoh H, et al. Among authors: yamashita yt. Anticancer Res. 1998 Mar-Apr;18(2A):1027-30. Anticancer Res. 1998. PMID: 9615759

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

62 results

Search Page

Filters